Anandamide-derived prostamide F2α negatively regulates adipogenesis

Journal of Biological Chemistry

Volumn 288, Issue 32, 2013, Pages 23307-23321

  Silvestri, Cristoforo ^a   Martella, Andrea ^a   Poloso, Neil J ^b   Piscitelli, Fabiana ^a   Capasso, Raffaele ^c   Izzo, Angelo ^c   Woodward, David F ^b   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

^b ALLERGAN INC   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTES; ADIPOGENESIS; ANANDAMIDE; ANTIOBESITY; FAT DEPOT; PREADIPOCYTES; REGULATORY MECHANISM;

BIOCHEMISTRY;

BIOLOGY;

ANANDAMIDE; BIMATOPROST; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN F2 ALPHA ETHANOLAMIDE; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAMIDE F2ALPHA; UNCLASSIFIED DRUG; AMIDE; ARACHIDONIC ACID DERIVATIVE; CYCLOOXYGENASE 2; DRUG DERIVATIVE; ENDOCANNABINOID; MAPK1 PROTEIN, HUMAN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2ALPHA ETHANOLAMIDE; PTGS2 PROTEIN, HUMAN; PTGS2 PROTEIN, MOUSE;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIADIPOGENIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; ENZYME PHOSPHORYLATION; EXPERIMENTAL MOUSE; HUMAN; HUMAN CELL; LIPID DIET; NEGATIVE FEEDBACK; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROADIPOCYTE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; WHITE ADIPOSE TISSUE; ZEBRA FISH; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CELL STRAIN 3T3; CYTOLOGY; FEMALE; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROSTAMIDE;

ADIPOGENESIS; ADIPOSE TISSUE; ANANDAMIDE; ENDOCANNABINOIDS; METABOLISM; PROSTAGLANDIN; PROSTAMIDE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ARACHIDONIC ACIDS; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOCANNABINOIDS; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; POLYUNSATURATED ALKAMIDES; ZEBRAFISH;

EID: 84880778840     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.489906     Document Type: Article

References (76)

1. Flier, J. S. (1995) The adipocyte. Storage depot or node on the energy information superhighway? Cell 80, 15-18
2. Rosen, E. D., and Spiegelman, B. M. (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853
3. Ouchi, N., Ohashi, K., Shibata, R., and Murohara, T. (2012) Adipocytokines and obesity-linked disorders. Nagoya J. Med. Sci. 74, 19-30
4. Garber, A. J. (2004) The metabolic syndrome. Med. Clin. N. Am. 88, 837-846, ix
5. Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., NAslund, E., Britton, T., Concha, H., Hassan, M., Rydén, M., Frisén, J., and Arner, P. (2008) Dynamics of fat cell turnover in humans. Nature 453, 783-787
6. Jo, J., Gavrilova, O., Pack, S., Jou, W., Mullen, S., Sumner, A. E., Cushman, S. W., and Periwal, V. (2009) Hypertrophy and/or hyperplasia. Dynamics of adipose tissue growth. PLoS Comput. Biol. 5, e1000324
7. Faust, I. M., Miller, W. H., Jr., Sclafani, A., Aravich, P. F., Triscari, J., and Sullivan, A. C. (1984) Diet-dependent hyperplastic growth of adipose tissue in hypothalamic obese rats. Am. J. Physiol. 247, R1038-R1046
8. Drolet, R., Richard, C., Sniderman, A. D., Mailloux, J., Fortier, M., Huot, C., Rheaume, C., and Tchernof, A. (2008) Int. J. Obes. 32, 283-291
9. Fajas, L., Fruchart, J. C., and Auwerx, J. (1998) Transcriptional control of adipogenesis. Curr. Opin. Cell Biol. 10, 165-173
10. Gregoire, F. M., Smas, C. M., and Sul, H. S. (1998) Understanding adipocyte differentiation. Physiol. Rev. 78, 783-809
11. Farmer, S. R. (2006) Transcriptional control of adipocyte formation. Cell Metab. 4, 263-273
12. Sandouk, T., Reda, D., and Hofmann, C. (1993) Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol. 264, C1600-C1608
13. Freytag, S. O., Paielli, D. L., and Gilbert, J. D. (1994) Ectopic expression of the CCAAT/enhancer-binding protein promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8, 1654-1663
14. Hu, E., Tontonoz, P., and Spiegelman, B. M. (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR and C/EBP. Proc. Natl. Acad. Sci. U.S.A. 92, 9856-9860
15. Matias, I., Gonthier, M. P., Orlando, P., Martiadis, V., De Petrocellis, L., Cervino, C., Petrosino, S., Hoareau, L., Festy, F., Pasquali, R., Roche, R., Maj, M., Pagotto, U., Monteleone, P., and Di Marzo, V. (2006) Regulation, function, and dysregulation of endocannabinoids in models of adipose and-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 91, 3171-3180
16. Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., and Jordan, J. (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54, 2838-2843
17. D'Eon, T. M., Pierce, K. A., Roix, J. J., Tyler, A., Chen, H., and Teixeira, S. R. (2008) The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 57, 1262-1268
18. Bouaboula, M., Hilairet, S., Marchand, J., Fajas, L., Le Fur, G., and Casellas, P. (2005) Anandamide induced PPARtranscriptional activation and 3T3-L1 preadipocyte differentiation. Eur. J. Pharmacol. 517, 174-181
19. Karaliota, S., Siafaka-Kapadai, A., Gontinou, C., Psarra, K., and Mavri-Vavayanni, M. (2009) Anandamide increases the differentiation of rat adipocytes and causes PPARand CB1 receptor upregulation. Obesity 17, 1830-1838
20. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., and Gilula, N. B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87
21. Koda, N., Tsutsui, Y., Niwa, H., Ito, S., Woodward, D. F., and Watanabe, K. (2004) Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme. New enzyme assay method using LC/ESI/MS. Arch. Biochem. Biophys. 424, 128-136
22. Moriuchi, H., Koda, N., Okuda-Ashitaka, E., Daiyasu, H., Ogasawara, K., Toh, H., Ito, S., Woodward, D. F., and Watanabe, K. (2008) Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily. J. Biol. Chem. 283, 792-801
23. Woodward, D. F., Carling, R. W., Cornell, C. L., Fliri, H. G., Martos, J. L., Pettit, S. N., Liang, Y., and Wang, J. W. (2008) The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol. Ther. 120, 71-80
24. Matias, I., Chen, J., De Petrocellis, L., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H., Shi, L., Protzman, C. E., Li, C., Liang, Y., Nieves, A. L., Kedzie, K. M., Burk, R. M., Di Marzo, V., and Woodward, D. F. (2004) Prostaglandin ethanolamides (prostamides). In vitro pharmacology and metabolism. J. Pharmacol. Exp. Ther. 309, 745-757
25. Chen, J., Senior, J., Marshall, K., Abbas, F., Dinh, H., Dinh, T., Wheeler, L., and Woodward, D. (2005) Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles. Br. J. Pharmacol. 144, 493-501
26. Woodward, D. F., Krauss, A. H., Chen, J., Lai, R. K., Spada, C. S., Burk, R. M., Andrews, S. W., Shi, L., Liang, Y., Kedzie, K. M., Chen, R., Gil, D. W., Kharlamb, A., Archeampong, A., Ling, J., Madhu, C., Ni, J., Rix, P., Usansky, J., Usansky, H., Weber, A., Welty, D., Yang, W., Tang-Liu, D. D., Garst, M. E., Brar, B., Wheeler, L. A., and Kaplan, L. J. (2001) The pharmacology of bimatoprost (Lumigan). Surv. Ophthalmol. 45, S337-S345
27. Woodward, D. F., Krauss, A. H., Wang, J. W., Protzman, C. E., Nieves, A. L., Liang, Y., Donde, Y., Burk, R. M., Landsverk, K., and Struble, C. (2007) Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris. Br. J. Pharmacol. 150, 342-352
28. Liang, Y., Woodward, D. F., Guzman, V. M., Li, C., Scott, D. F., Wang, J. W., Wheeler, L. A., Garst, M. E., Landsverk, K., Sachs, G., Krauss, A. H., Cornell, C., Martos, J., Pettit, S., and Fliri, H. (2008) Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br. J. Pharmacol. 154, 1079-1093
29. Crofford, L. J. (2001) Prostaglandin biology. Gastroenterol. Clin. North Am. 30, 863-876
30. Tsuboi, K., Sugimoto, Y., and Ichikawa, A. (2002) Prostaglandins Other Lipid Mediat. 68-69, 535-556
31. Matsuoka, T., and Narumiya, S. (2007) Prostaglandin receptor signaling in disease. Scientific World Journal 7, 1329-1347
32. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995) 15-Deoxy 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR. Cell 83, 803-812
33. Tanaka, A., Nomura, Y., Matsuda, A., Ohmori, K., and Matsuda, H. (2011) Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-12, 14-prostaglandin J2. Am. J. Physiol. Cell Physiol. 301, C1360-C1367
34. Miller, C. W., Casimir, D. A., and Ntambi, J. M. (1996) The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2. Endocrinology 137, 5641-5650
35. Reginato, M. J., Krakow, S. L., Bailey, S. T., and Lazar, M. A. (1998) Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor. J. Biol. Chem. 273, 1855-1858
36. Liu, L., and Clipstone, N. A. (2007) Prostaglandin F2inhibits adipocyte differentiation via aGq-calcium-calcineurin-dependent signaling pathway. J. Cell Biochem. 100, 161-173
37. Woodward, D. F., Liang, Y., and Krauss, A. H. (2008) Prostamides (prostaglandin-ethanolamides) and their pharmacology. Br. J. Pharmacol. 153, 410-419
38. Peplinski, L. S., and Albiani Smith, K. (2004) Deepening of lid sulcus from topical bimatoprost therapy. Optom. Vis. Sci. 81, 574-577
39. Filippopoulos, T., Paula, J. S., Torun, N., Hatton, M. P., Pasquale, L. R., and Grosskreutz, C. L. (2008) Periorbital changes associated with topical bimatoprost. Ophthal. Plast. Reconstr. Surg. 24, 302-307
40. Yam, J. C., Yuen, N. S., and Chan, C. W. (2009) Bilateral deepening of upper lid sulcus from topical bimatoprost therapy. J. Ocul. Pharmacol. Ther. 25, 471-472
41. Aydin, S., Iikligil, I., Teken, Y. A., and Kir, E. (2010) Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy. 2 case reports and review of the literature. Cutan. Ocul. Toxicol. 29, 212-216
42. Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., and Kunos, G. (2001) Leptinregulated endocannabinoids are involved in maintaining food intake. Nature 410, 822-825
43. Blaho, V. A., Buczynski, M. W., Brown, C. R., and Dennis, E. A. (2009) Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J. Biol. Chem. 284, 21599-21612
44. Hall, L. M., and Murphy, R. C. (1998) Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J. Am. Soc. Mass Spectrom 9, 527-532
45. Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A., Maione, S., and Di Marzo, V. (2012) Discovery of prostamide F2and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability. PLoS ONE 7, e31111
46. Fujimori, K., Ueno, T., Nagata, N., Kashiwagi, K., Aritake, K., Amano, F., and Urade, Y. (2010) Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2synthase. J. Biol. Chem. 285, 8880-8886
47. Flynn, E. J., 3rd, Trent, C. M., and Rawls, J. F. (2009) Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). J. Lipid Res. 50, 1641-1652
48. Imrie, D., and Sadler, K. C. (2010) White adipose tissue development in zebrafish is regulated by both developmental time and fish size. Dev. Dyn. 239, 3013-3023
49. Rebuffé-Scrive, M., Surwit, R., Feinglos, M., Kuhn, C., and Rodin, J. (1993) Regional fat distribution and metabolism in a new mouse model (C57BL/ 6J) of non-insulin-dependent diabetes mellitus. Metabolism 42, 1405-1409
50. Tchoukalova, Y. D., Votruba, S. B., Tchkonia, T., Giorgadze, N., Kirkland, J. L., and Jensen, M. D. (2010) Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc. Natl. Acad. Sci. U.S.A. 107, 18226-18231
51. Duggan, K. C., Hermanson, D. J., Musee, J., Prusakiewicz, J. J., Scheib, J. L., Carter, B. D., Banerjee, S., Oates, J. A., and Marnett, L. J. (2011) (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat. Chem. Biol. 7, 803-809
52. Ueno, T., and Fujimori, K. (2011) Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2receptor mediated activation of MEK/ERK-CREB cascade. FEBS J. 278, 2901-2912
53. Goetzl, E. J., An, S., and Smith, W. L. (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9, 1051-1058
54. Jez, J. M., Bennett, M. J., Schlegel, B. P., Lewis, M., and Penning, T. M. (1997) Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 326, 625-636
55. Di Marzo, V. (2011) Endocannabinoid signaling in the brain. Biosynthetic mechanisms in the limelight. Nat. Neurosci. 14, 9-15
56. Woodward, D. F., Phelps, R. L., Krauss, A. H., Weber, A., Short, B., Chen, J., Liang, Y., and Wheeler, L. A. (2004) Bimatoprost. A novel antiglaucoma agent. Cardiovasc. Drug Rev. 22, 103-120
57. Woodward, J. A., Haggerty, C. J., Stinnett, S. S., and Williams, Z. Y. (2010) Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement. J. Cosmet. Dermatol. 9, 96-102
58. Park, J., Cho, H. K., and Moon, J. I. (2011) Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn. J. Ophthalmol. 55, 22-27
59. Serrero, G., Lepak, N. M., and Goodrich, S. P. (1992) Paracrine regulation of adipose differentiation by arachidonate metabolites. Prostaglandin F2inhibits early and late markers of differentiation in the adipogenic cell line 1246. Endocrinology 131, 2545-2551
60. Serrero, G., and Lepak, N. M. (1997) Prostaglandin F2receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem. Biophys. Res. Commun. 233, 200-202
61. Jeong, W. I., Osei-Hyiaman, D., Park, O., Liu, J., Bátkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., Gao, B., and Kunos, G. (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab. 7, 227-235
62. Choi, H. Y., Lee, J. E., Lee, J. W., Park, H. J., Lee, J. E., and Jung, J. H. (2012) In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadipocytes. J. Ocul. Pharmacol. Ther. 28, 146-152
63. Fujimori, K., Ueno, T., and Amano, F. (2010) Prostaglandin F(2) suppresses early phase of adipogenesis, but is not associated with osteoblastogenesis in mouse mesenchymal stem cells. Prostaglandins Other Lipid Mediat. 93, 52-59
64. Kwok, A. H., Wang, Y., and Leung, F. C. (2012) Molecular characterization of prostaglandin F receptor (FP) and E receptor subtype 1 (EP1) in zebrafish. Gen. Comp. Endocrinol. 178, 216-226
65. Grosser, T., Yusuff, S., Cheskis, E., Pack, M. A., and FitzGerald, G. A. (2002) Developmental expression of functional cyclooxygenases in zebrafish. Proc. Natl. Acad. Sci. U.S.A. 99, 8418-8423
66. Maccarrone, M., Gasperi, V., Fezza, F., Finazzi-Agrò, A., and Rossi, A. (2004) Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone. Eur. J. Biochem. 271, 4666-4676
67. Yan, H., Kermouni, A., Abdel-Hafez, M., and Lau, D. C. (2003) Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J. Lipid Res. 44, 424-429
68. Jabbour, H. N., Sales, K. J., Boddy, S. C., Anderson, R. A., and Williams, A. R. (2005) A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway. Endocrinology 146, 4657-4664
69. Taniguchi, K., Matsuoka, A., Kizuka, F., Lee, L., Tamura, I., Maekawa, R., Asada, H., Taketani, T., Tamura, H., and Sugino, N. (2010) Prostaglandin F2(PGF2) stimulates PTGS2 expression and PGF2synthesis through NFKB activation via reactive oxygen species in the corpus luteum of pseudopregnant rats. Reproduction 140, 885-892
70. Nishimura, S., Manabe, I., Nagasaki, M., Hosoya, Y., Yamashita, H., Fujita, H., Ohsugi, M., Tobe, K., Kadowaki, T., Nagai, R., and Sugiura, S. (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56, 1517-1526
71. Tang, W., Zeve, D., Suh, J. M., Bosnakovski, D., Kyba, M., Hammer, R. E., Tallquist, M. D., and Graff, J. M. (2008) White fat progenitor cells reside in the adipose vasculature. Science 322, 583-586
72. Hutley, L. J., Herington, A. C., Shurety, W., Cheung, C., Vesey, D. A., Cameron, D. P., and Prins, J. B. (2001) Human adipose tissue endothelial cells promote preadipocyte proliferation. Am. J. Physiol. Endocrinol. Metab. 281, E1037-E1044
73. Jimenez de Asua, L., Carr, B., Clingan, D., and Rudland, P. (1977) Specific glucocorticoid inhibition of growth promoting effects of prostaglandin F2on 3T3 cells. Nature 265, 450-452
74. Taylor, L., Foxall, T., Auger, K., Heinsohn, C., and Polgar, P. (1987) Comparison of prostaglandin synthesis by endothelial cells from blood vessels originating in the rat, baboon, calf and human. Atherosclerosis 65, 227-236
75. Bensaid, M., Gary-Bobo, M., Esclangon, A., Maffrand, J. P., Le Fur, G., Oury-Donat, F., and Soubrié, P. (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol. Pharmacol. 63, 908-914
76. Weber, A., Ni, J., Ling, K. H., Acheampong, A., Tang-Liu, D. D., Burk, R., Cravatt, B. F., and Woodward, D. (2004) Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. J. Lipid Res. 45, 757-763